Latest News

Stay up to date with the latest stock market news from around the world. From breaking news written by our finance analysts to event-driven market news on a global scale.

NasdaqGS:IQ
NasdaqGS:IQEntertainment

A Look At iQIYI (IQ) Valuation After CFO Resignation And Strong Content Performance News

iQIYI (IQ) is back on traders’ radar after the immediate resignation of long-time CFO Jun Wang, the appointment of interim finance head Ying Zeng, and new headlines on content performance and international viewership. See our latest analysis for iQIYI. The CFO change and strong content headlines have arrived after a mixed run for shareholders, with a 7 day share price return of 4.9% and a 1 month share price return of 7.1%, but a 1 year total shareholder return decline of 8.7% and a 5 year...
NYSE:GBCI
NYSE:GBCIBanks

Glacier Bancorp (GBCI) Valuation Check After Mixed Short And Long Term Share Returns

Why Glacier Bancorp Stock Is On Investors’ Radar Today Glacier Bancorp (GBCI) has drawn fresh attention after recent share moves, with the stock showing mixed short term returns and a monthly gain along with a past 3 months increase and a 1 year decline. See our latest analysis for Glacier Bancorp. Glacier Bancorp’s recent pullback, with a 1 day share price return of 3.75% decline to $48.0, sits against a 30 day share price return of 4.83% and a 90 day share price return of 9.46%. Its 1 year...
NYSE:WES
NYSE:WESOil and Gas

Will Western Midstream’s New Fixed-Fee Deals and Payout Shift Change Western Midstream Partners' (WES) Narrative

Western Midstream Partners, LP recently declared a fourth-quarter 2025 cash distribution of US$0.910 per unit, payable on February 13, 2026, while simultaneously overhauling key Delaware Basin natural-gas gathering and processing contracts with Occidental Petroleum and adding a new fixed-fee agreement with ConocoPhillips. By shifting from cost-of-service to fixed-fee contracts, modestly reducing Occidental’s ownership stake, and lowering related-party revenue concentration, Western Midstream...
NYSEAM:BHB
NYSEAM:BHBBanks

Bar Harbor Bankshares (BHB) Margin Compression Challenges Bullish Earnings Growth Narrative

Bar Harbor Bankshares (BHB) just closed out FY 2025 with fourth quarter total revenue of US$48.2 million and basic EPS of US$0.70, supported by net income of US$11.8 million, while trailing twelve month figures show revenue of US$163.4 million and EPS of US$2.32. Over recent periods, quarterly revenue has moved from US$38.4 million in Q3 2024 to US$37.4 million in Q4 2024, then to US$37.3 million in Q1 2025 and US$44.0 million in Q3 2025 before reaching US$48.2 million in Q4 2025, as EPS...
NasdaqGM:OPBK
NasdaqGM:OPBKBanks

OP Bancorp (OPBK) Net Margin Expansion Reinforces Bullish Profitability Narratives

OP Bancorp’s FY 2025 earnings snapshot OP Bancorp (OPBK) closed FY 2025 with fourth quarter revenue of US$23.8 million and basic EPS of US$0.47. Trailing twelve month revenue reached US$91.1 million and EPS came in at US$1.73 alongside 24% earnings growth over the past year. Over recent periods the company has seen revenue move from US$79.3 million and EPS of US$1.39 on a trailing basis in late 2024 to US$91.1 million and US$1.73 respectively. The trailing net profit margin stepped up from...
NasdaqGM:USCB
NasdaqGM:USCBBanks

USCB Financial Holdings (USCB) Net Margin Strength Reinforces Bullish Narratives Despite Mixed P/E Signals

USCB Financial Holdings (USCB) has wrapped up FY 2025 with fourth quarter total revenue of US$17.5 million and EPS of about US$0.08, capping a 12 month stretch where trailing revenue reached US$87.9 million and EPS came in at US$1.44. Over that same period, net income on a trailing basis was US$26.1 million, and investors may now focus on how the latest quarter fits into a year of higher margins and earnings growth. With a full year net margin of 34.3% compared with 28.5% in the prior year,...
NYSE:ZTS
NYSE:ZTSPharmaceuticals

How Soft Guidance And Innovation Concerns At Zoetis (ZTS) Have Changed Its Investment Story

In recent months, Zoetis reported quarterly revenues of about US$2.40 billion that were flat year on year, alongside full-year guidance that came in slightly below analysts’ expectations, and the company was downgraded by Piper Sandler amid concern about an “innovation air pocket” over the next couple of years. At the same time, Zoetis continues to lean on a broad animal health portfolio and a pipeline of 12 potential blockbuster therapies, with management aiming for at least one major...
TSXV:ITR
TSXV:ITRMetals and Mining

A Look At Integra Resources (TSXV:ITR) Valuation After Key FAST-41 And Federal Permitting Milestones

Integra Resources (TSXV:ITR) is back in focus after securing two key regulatory milestones for its DeLamar Heap Leach Project in Idaho, including entry into the U.S. FAST-41 transparency program and a defined federal permitting schedule. See our latest analysis for Integra Resources. The regulatory progress around DeLamar seems to line up with a strong run in Integra Resources’ shares, with a 57.86% 90 day share price return and a very large 1 year total shareholder return, although the 5...
NasdaqGS:JD
NasdaqGS:JDMultiline Retail

Assessing JD.com (NasdaqGS:JD) Valuation As Buybacks AI Demand And Global Expansion Draw Fresh Attention

Why JD.com (JD) is back on investors’ radar JD.com (JD) has been buying back and cancelling a large block of Class A shares, reporting very strong demand in certain artificial intelligence product lines, and outlining fresh global expansion through its National Pavilion online shops. See our latest analysis for JD.com. Recent moves such as large scale share buybacks, strong demand for AI related products and fresh international expansion plans come against a mixed backdrop, with a 7 day share...
NasdaqGS:CRNX
NasdaqGS:CRNXPharmaceuticals

Crinetics Starts Pediatric BALANCE CAH Trial As Valuation Gap Persists

Crinetics Pharmaceuticals has begun dosing pediatric patients in its Phase 2/3 BALANCE-CAH trial of atumelnant for classic congenital adrenal hyperplasia. Atumelnant is described as a first in class oral ACTH receptor antagonist and is currently the only small molecule in late stage development targeting this mechanism. The program received FDA Orphan Drug Designation for classic congenital adrenal hyperplasia, highlighting the focus on a rare pediatric condition with significant unmet...
NYSE:BHE
NYSE:BHEElectronic

Does Benchmark Electronics’ End‑Market Strain And Thin Free Cash Flow Reshape Its Investment Story (BHE)?

Benchmark Electronics, Inc. previously announced it would release its fourth quarter and fiscal 2025 results on February 3, 2026, followed by a same-day conference call and webcast for investors. This update comes as the company contends with end-market headwinds, declining sales, subdued earnings growth, and a constrained free cash flow profile. We’ll now examine how these end-market challenges and thin free cash flow margins shape Benchmark Electronics’ broader investment narrative. We've...
NasdaqGS:AUR
NasdaqGS:AURSoftware

How Investors Are Reacting To Aurora Innovation (AUR) Integrating Aurora Driver Into McLeod’s Freight Platform

In January 2026, McLeod Software and Aurora Innovation announced they had completed an ahead-of-schedule API integration that lets eligible McLeod transportation management system customers book and manage Aurora Driver–powered autonomous truck capacity directly within their existing workflows, with real-time tracking and automated status updates already being used by early adopter Russell Transport. This integration reduces friction for carriers adopting autonomous trucking by embedding...
TSE:8952
TSE:8952Office REITs

A Look At Japan Real Estate Investment (TSE:8952) Valuation After The Planned Kandabashi Park Building Acquisition

Japan Real Estate Investment (TSE:8952) has moved to expand its Tokyo office footprint with a planned additional acquisition in the Kandabashi Park Building, a central business property that has recently undergone value-add renovations. See our latest analysis for Japan Real Estate Investment. The planned Kandabashi Park Building acquisition comes after a softer patch for the units, with a 7 day share price return of 3.29% decline and a year to date share price return of 2.99% decline. This...
NYSE:TUYA
NYSE:TUYASoftware

Assessing Tuya (TUYA) Valuation After Aura AI Pet Robot Debut At CES 2026

Tuya (TUYA) has drawn fresh attention after unveiling Aura, an AI-powered pet companion robot, at CES 2026. This launch signals a move beyond traditional smart devices into pet care and home service robotics. See our latest analysis for Tuya. Despite the CES spotlight, Tuya’s recent trading has been subdued, with a 7.69% decline in its 90 day share price return and a 19.42% fall in the three year total shareholder return. This suggests momentum has been under pressure even as new products...
TSE:3994
TSE:3994Software

Money Forward (TSE:3994) Is Down 12.8% After Issuing Wide FY26 Loss-Profit Guidance Range

In January 2026, Money Forward, Inc. held a board meeting to consider issuing new shares as restricted stock compensation and released consolidated earnings guidance for the fiscal year ending November 30, 2026, projecting net sales of ¥53,400 million to ¥57,550 million and an operating result ranging from a ¥2,500 million loss to a ¥500 million profit. The company also signaled continued investment by forecasting a loss attributable to owners of parent of ¥5,200 million to ¥2,200 million,...
NYSE:RCL
NYSE:RCLHospitality

Royal Caribbean Pursues Connected Vacation Vision After Admired Companies Honor

Royal Caribbean Cruises (NYSE:RCL) has been named to Fortune's World's Most Admired Companies 2026 list. The company is expanding a connected vacation ecosystem, including new ship classes, river cruising entry, and larger private destination investments. Royal Caribbean has introduced an industry first loyalty program refresh and launched its Port Partners accelerator to support local businesses in Alaska. Royal Caribbean Cruises, trading at $286.11, is in the spotlight with its inclusion...